Kirchoff et al (2004) tested 251 unselected Ashkenazi Jewish men with prostate cancer from the New York area for the two founder mutations in BRCA1 and the one in BRCA2. They also tested 1472 Ashkenazi controls. Here, BRCA2 is linked to prostate carcinoma.